Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 4.87 USD 2.53% Market Closed
Market Cap: 161.6m USD
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Investor Relations

Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Patrick Amstutz Ph.D.
Co-Founder, CEO, Member of Management Board & Director
No Bio Available
Dr. Michael Tobias Stumpp Ph.D.
Co-Founder, Executive VP of Projects & Member of Management Board
No Bio Available
Mr. Robert Hendriks
Senior VP of Finance
No Bio Available
Mr. Alexander Zurcher
COO & Member of Management Board
No Bio Available
Ms. Renate Gloggner
Executive VP of People & Community and Member of Management Board
No Bio Available
Mr. Daniel Steiner Ph.D.
Senior Vice President of Research & Technology
No Bio Available
Mr. Seth D. Lewis
Senior Vice President of Investor Relations, Communications & Strategy
No Bio Available
Mr. Michael Pitzner
General Counsel, Compliance Officer, Senior VP Legal & Business Development
No Bio Available
Dr. Pamela A. Trail Ph.D.
Strategic Consultant
No Bio Available
Ms. Anne Goubier D.V.M., Ph.D.
Senior Vice President of Research & Early Development
No Bio Available

Contacts

Address
ZUERICH
Schlieren
Wagistrasse 14
Contacts